<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> neutrophil (PMN) recruitment to postischemic cardiac or pulmonary tissue has deleterious effects in the early reperfusion period, but the mechanisms and effects of neutrophil influx in the pathogenesis of evolving <z:hpo ids='HP_0001297'>stroke</z:hpo> remain controversial </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate whether PMNs contribute to adverse neurologic sequelae and mortality after <z:hpo ids='HP_0001297'>stroke</z:hpo>, and to study the potential role of the leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (ICAM-1) in the pathogenesis of <z:hpo ids='HP_0001297'>stroke</z:hpo>, we used a murine model of transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> consisting of intraluminal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 45 min followed by 22 h of reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>PMN accumulation, monitored by deposition of 111In-labeled PMNs in postischemic cerebral tissue, was increased 2.5-fold in the ipsilateral (infarcted) hemisphere compared with the contralateral (noninfarcted) hemisphere (P &lt; 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>Mice immunodepleted of neutrophils before surgery demonstrated a 3.0-fold reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes (P &lt; 0.001), based on triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining of serial cerebral sections, improved ipsilateral cortical cerebral blood flow (measured by laser Doppler), and reduced neurological deficit compared with controls </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:mp ids='MP_0002169'>wild-type</z:mp> mice subjected to 45 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> followed by 22 h of reperfusion, ICAM-1 mRNA was increased in the ipsilateral hemisphere, with immunohistochemistry localizing increased ICAM-1 expression on cerebral microvascular endothelium </plain></SENT>
<SENT sid="5" pm="."><plain>The role of ICAM-1 expression in <z:hpo ids='HP_0001297'>stroke</z:hpo> was investigated in homozygous null ICAM-1 mice (ICAM-1 -/-) in comparison with <z:mp ids='MP_0002169'>wild-type</z:mp> controls (ICAM-1 +/+) </plain></SENT>
<SENT sid="6" pm="."><plain>ICAM-1 -/- mice demonstrated a 3.7-fold reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (P &lt; 0.005), a 35% increase in survival (P &lt; 0.05), and reduced neurologic deficit compared with ICAM-1 +/+ controls </plain></SENT>
<SENT sid="7" pm="."><plain>Cerebral blood flow to the infarcted hemisphere was 3.1-fold greater in ICAM-1 -/- mice compared with ICAM-1 +/+ controls (P &lt; 0.01), suggesting an important role for ICAM-1 in the genesis of postischemic cerebral no-reflow </plain></SENT>
<SENT sid="8" pm="."><plain>Because PMN-depleted and ICAM-1-deficient mice are relatively resistant to <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion injury, these studies suggest an important role for ICAM-1-mediated PMN <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in the pathophysiology of evolving <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>